Categories: News

NHI Announces Second Quarter 2021 Earnings Release and Conference Call Dates

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MURFREESBORO, TN / ACCESSWIRE / July 9, 2021 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the second quarter ended June 30, 2021. NHI plans to issue its earnings release after the market closes on Monday, August 9, 2021, and will host a conference call on the following day, Tuesday, August 10, 2021, at 12 p.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (800) 952-1438, with the confirmation number 21995595.

The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/41897 on Tuesday, August 10, 2021, at 12 p.m. Eastern Time. The online replay will be available shortly after the call and remain available for one year.

About NHI

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit www.nhireit.com.

Contact: 

Dana Hambly
Vice President, Investor Relations
Phone: (615) 890-9100

SOURCE: National Health Investors

View source version on accesswire.com:
https://www.accesswire.com/654954/NHI-Announces-Second-Quarter-2021-Earnings-Release-and-Conference-Call-Dates

Staff

Recent Posts

Morgan AH Medical Unveils Patented Rolling Expandable Bathtub at Abilities Expo Chicago – Hailed as a “Game Changer” for Accessible Bathing

Chicago, Illinois--(Newsfile Corp. - July 3, 2025) - Morgan AH Medical made headlines at this…

56 minutes ago

Hemostemix Announces its 10th Publication: A Molecular Strategy for the Treatment of Heart Failure: Response to BioCardia’s Cardiamp Heart Failure Trial

Calgary, Alberta--(Newsfile Corp. - July 3, 2025) -  Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0)…

56 minutes ago

Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com

North Bergen, New Jersey--(Newsfile Corp. - July 3, 2025) - Apollo Biowellness, Inc. (OTC Pink:…

2 hours ago

AAMI Aligns With National Academy of Medicine AI Code of Conduct

AI Code of Conduct’s six core principles key to ensuring the safe and effective use…

3 hours ago

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0)…

3 hours ago